Bioventus Inc Cl A (BVS)
7.81 x 5 7.82 x 77
Post-market by (Cboe BZX)
7.82 +0.04 (+0.51%) 04/17/25 [NASDAQ]
7.81 x 5 7.82 x 77
Post-market 7.82 unch (unch) 16:07 ET
for Thu, Apr 17th, 2025
Results
download Want to compare other data? Select Fields| Symbol | BVS | CRON | XERS | ||
| Company | Bioventus Inc Cl A | Cronos Group Inc | Xeris Pharmaceuticals Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 7.74 | 1.7800 | 4.08 | ||
| High | 7.88 | 1.7963 | 4.20 | ||
| Low | 7.59 | 1.7001 | 4.04 | ||
| Last | 7.82 | 1.7700 | 4.11 | ||
| Change | +0.04 | unch | +0.03 | ||
| % Change | +0.51% | unch | +0.74% | ||
| Volume | 323,500 | 2,254,300 | 1,906,600 | ||
| 20-Day Average Volume | 339,150 | 1,596,675 | 3,780,485 | ||
| Previous Close | 7.78 | 1.7700 | 4.08 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 8.59 | 1.7625 | 4.86 | ||
| 20-Day Raw Stochastic | 24.21% | 60.71% | 13.47% | ||
| 20-Day Relative Strength | 38.33% | 46.63% | 44.01% | ||
| Weighted Alpha | +21.13 | -27.65 | +117.72 | ||
| Today's Opinion | 88% Sell | 88% Sell | 56% Buy | ||
| Previous Opinion | 88% Sell | 88% Sell | 56% Buy | ||
| Last Month's Opinion | 16% Sell | 100% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.30% since 04/10/25 | +5.36% since 04/10/25 | +4.05% since 04/10/25 | ||
| Low | 7.13 on 04/11/25 | 1.6500 on 04/11/25 | 3.84 on 04/11/25 | ||
| High | 8.14 on 04/15/25 | 1.8197 on 04/16/25 | 4.39 on 04/15/25 | ||
| 1-Month | |||||
| %Chg | -20.20% since 03/17/25 | -6.84% since 03/17/25 | -18.29% since 03/17/25 | ||
| Low | 7.13 on 04/11/25 | 1.6000 on 04/09/25 | 3.81 on 04/10/25 | ||
| High | 10.13 on 03/20/25 | 1.9200 on 03/18/25 | 6.07 on 03/26/25 | ||
| 3-Month | |||||
| %Chg | -22.11% since 01/17/25 | -11.06% since 01/17/25 | +28.44% since 01/17/25 | ||
| Low | 7.13 on 04/11/25 | 1.6000 on 04/09/25 | 3.21 on 01/21/25 | ||
| High | 11.25 on 03/11/25 | 2.1200 on 02/05/25 | 6.07 on 03/26/25 | ||
| 6-Month | |||||
| %Chg | -37.69% since 10/17/24 | -17.67% since 10/17/24 | +35.20% since 10/17/24 | ||
| Low | 7.13 on 04/11/25 | 1.6000 on 04/09/25 | 2.82 on 11/18/24 | ||
| High | 14.38 on 11/04/24 | 2.3400 on 11/12/24 | 6.07 on 03/26/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 640,802 | 682,170 | 632,693 | ||
| Shares Outstanding, K | 81,944 | 385,407 | 153,940 | ||
| Annual Sales | 573,280,000 | 117,620,000 | 203,070,000 | ||
| Annual Net Income | -33,540,000 | 41,080,000 | -54,840,000 | ||
| Last Quarter Sales | 153,640,000 | 30,300,000 | 60,100,000 | ||
| Last Quarter Net Income | -160,000 | 43,730,000 | -5,110,000 | ||
| 60-Month Beta | 0.92 | 1.02 | 1.37 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.15 on 03/11/25 | -0.01 on 02/27/25 | -0.03 on 03/06/25 | ||
| Latest Earnings Date | 05/06/25 | 05/08/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 16.55 | 0.00 | 0.00 | ||